Cargando…

Personalisation of Molecular Radiotherapy through Optimisation of Theragnostics

Molecular radiotherapy, or targeted radionuclide therapy, uses systemically administered drugs bearing a suitable radioactive isotope, typically a beta emitter. These are delivered via metabolic or other physiological pathways to cancer cells in greater concentrations than to normal tissues. The abs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davis, LauraMay, Smith, April-Louise, Aldridge, Matthew D., Foulkes, Jack, Peet, Connie, Wan, Simon, Gains, Jennifer E., Bomanji, Jamshed B., Gaze, Mark N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711590/ https://www.ncbi.nlm.nih.gov/pubmed/33081161 http://dx.doi.org/10.3390/jpm10040174

Ejemplares similares

Optimisation of clinical SPECT imaging with 155Tb for theragnostic radionuclide therapy
por: Cocolios, Thomas Elias, et al.
Publicado: (2016)

Radiomics-Based Texture Analysis of (68)Ga-DOTATATE Positron Emission Tomography and Computed Tomography Images as a Prognostic Biomarker in Adults With Neuroendocrine Cancers Treated With (177)Lu-DOTATATE
por: Atkinson, Charlotte, et al.
Publicado: (2021)

Clinical Feasibility Study of Gold Nanoparticles as Theragnostic Agents for Precision Radiotherapy
por: López-Valverde, José Antonio, et al.
Publicado: (2022)

THUNDER 2: THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI guided radiotherapy
por: Chiloiro, Giuditta, et al.
Publicado: (2022)

Theragnostic Aspects and Radioimmunotherapy in Pediatric Tumors
por: Cimini, Andrea, et al.
Publicado: (2020)

Shifting emphasis from pharmacogenomics to theragnostics
por: Ozdemir, Vural, et al.
Publicado: (2006)

Bacteriophages as Solid Tumor Theragnostic Agents
por: Veeranarayanan, Srivani, et al.
Publicado: (2021)

Molecular Imaging and Theragnostics of Thyroid Cancers
por: Giovanella, Luca, et al.
Publicado: (2022)

Aptamers as Theragnostic Tools in Prostate Cancer
por: Cruz-Hernández, Carlos David, et al.
Publicado: (2022)

Image guidance and interfractional anatomical variation in paediatric abdominal radiotherapy
por: Taylor, Sabrina, et al.
Publicado: (2023)

The potential of exosomes as theragnostics in various clinical situations
por: Kang, Ju-Seop
Publicado: (2020)

Nuclear Medicine and Cancer Theragnostics: Basic Concepts
por: Zoi, Vasiliki, et al.
Publicado: (2023)

Topological Optimisation Structure Design for Personalisation of Hydrogel Controlled Drug Delivery System
por: Gao, Yang, et al.
Publicado: (2023)

Metabolic lesion-deficit mapping of human cognition
por: Jha, Ashwani, et al.
Publicado: (2020)

Risk of radiation-induced second malignant neoplasms from photon and proton radiotherapy in paediatric abdominal neuroblastoma
por: Taylor, Sophie, et al.
Publicado: (2021)

A combination of surgery, theranostics, and liquid biopsy - a personalised oncologic approach to treatment of patients with advanced metastatic neuroendocrine neoplasms
por: Frilling, Andrea, et al.
Publicado: (2021)

Necrosis targeted combinational theragnostic approach to treat cancer
por: Ji, Yun, et al.
Publicado: (2014)

Theragnostic ultrasound using microbubbles in the treatment of prostate cancer
por: Lee, Hak Jong, et al.
Publicado: (2016)

Tumor microenvironment-responsive nanoparticles for cancer theragnostic applications
por: Uthaman, Saji, et al.
Publicado: (2018)

Theragnostic potentials of core/shell mesoporous silica nanostructures
por: Ravindran Girija, Aswathy, et al.
Publicado: (2019)

What Is Known about Theragnostic Strategies in Colorectal Cancer
por: Parisi, Alessandro, et al.
Publicado: (2021)

Radiation Dosimetry of Theragnostic Pairs for Isotopes of Iodine in IAZA
por: Jans, Hans-S., et al.
Publicado: (2022)

PSMA theragnostics for metastatic castration resistant prostate cancer
por: Song, Hong, et al.
Publicado: (2022)

Microfluidic Fabrication of Gadolinium-Doped Hydroxyapatite for Theragnostic Applications
por: Somoza, Manuel, et al.
Publicado: (2023)

Metabolic Priming as a Tool in Redox and Mitochondrial Theragnostics
por: Pinho, Sónia A., et al.
Publicado: (2023)

Using systematic reviews to identify research gaps - a case study: mIBG for the treatment of neuroblastoma in children
por: Wilson, Jayne, et al.
Publicado: (2013)

Impact of (18)F-fluciclovine PET/CT on salvage radiotherapy plans for men with recurrence of prostate cancer postradical prostatectomy
por: Payne, Heather, et al.
Publicado: (2021)

Nomogram for the personalisation of radiotherapy treatments in breast cancer patients
por: Beato Tortajada, Inmaculada, et al.
Publicado: (2021)

Impact of cyclic changes in pharmacokinetics and absorbed dose in pediatric neuroblastoma patients receiving [(177)Lu]Lu-DOTATATE
por: Malcolm, Javian C., et al.
Publicado: (2022)

Deep learning based synthetic CT from cone beam CT generation for abdominal paediatric radiotherapy
por: Szmul, Adam, et al.
Publicado: (2023)

Theragnostic Imaging Using Radiolabeled Antibodies and Tyrosine Kinase Inhibitors
por: Yoshimoto, Mitsuyoshi, et al.
Publicado: (2015)

Magnetic Dehydrodipeptide-Based Self-Assembled Hydrogels for Theragnostic Applications
por: Carvalho, André, et al.
Publicado: (2019)

Prostate-specific membrane antigen-mediated theragnostics in prostate cancer
por: Jeong, Seung-hwan, et al.
Publicado: (2021)

Nanomaterials as Ultrasound Theragnostic Tools for Heart Disease Treatment/Diagnosis
por: Alphandéry, Edouard
Publicado: (2022)

Synthesis and Characterization of Magnetic Composite Theragnostics by Nano Spray Drying
por: Perecin, Caio José, et al.
Publicado: (2022)

Glioma extracellular vesicles for precision medicine: prognostic and theragnostic application
por: Marei, Hany E., et al.
Publicado: (2022)

Optimised deep neural network model to predict asthma exacerbation based on personalised weather triggers
por: Haque, Radiah, et al.
Publicado: (2021)

Does relative renal function improve after intervention for chronic ureteric obstruction?
por: Low, Zhi-Yang, et al.
Publicado: (2021)

Treatment-integrated imaging, radiomics, and personalised radiotherapy: the future is at hand
por: Malicki, Julian, et al.
Publicado: (2022)

THeragnostic utilities for neoplastic DisEases of the rectum by MRI guided radiotherapy (THUNDER 2) phase II trial: interim safety analysis
por: Chiloiro, Giuditta, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a7esj2dqe23cfd01odbs8nj5i7